Internal Medicine, Hematology & Oncology · Stuart, FL
NPI
1174720734
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
501 SE Osceola St Ste 301
Stuart, FL, 34994
Phone (772) 223-5955
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.3M
363,801 services
Medicare patients, 2024
739
Average age 76
Drug cost, 2024
$10.4M
2,854 prescriptions
Company payments, 2025
$4,946
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph My was code J1439 (injection, ferric carboxymaltose, 1 mg), 125,250 times for 68 patients. In total Joseph My billed 363,801 services in 169 codes, and Medicare paid $4.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 125,250 | 68 | $0.86 | $108K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 16,000 | 88 | $0.10 | $1,646 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 13,140 | 15 | $2.38 | $31K |
| J0185 Injection, aprepitant, 1 mg | Office | 9,750 | 20 | $1.34 | $13K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 9,400 | 24 | $4.39 | $41K |
| J0897 Injection, denosumab, 1 mg | Office | 9,180 | 23 | $20.60 | $189K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,099 | 52 | $0.09 | $367 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,092 | 11 | $20.54 | $84K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,200 | 19 | $6.54 | $21K |
| 85025 Blood Count | Office | 2,954 | 529 | $7.61 | $22K |
| 36415 Venipuncture Blood Collection | Office | 1,918 | 470 | $8.65 | $17K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,900 | 11 | $14.65 | $28K |
| 80053 Clinical Chemistry | Office | 1,366 | 390 | $10.35 | $14K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,350 | 20 | $0.68 | $923 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,344 | 13 | $0.07 | $97.81 |
By year: 2022 $3.7M for 182,832 services; 2023 $4.2M for 196,055 services; 2024 $4.3M for 363,801 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,954 | 529 | $7.61 | $22K |
| 36415 Venipuncture Blood Collection | 1,918 | 470 | $8.65 | $17K |
| 80053 Clinical Chemistry | 1,366 | 390 | $10.35 | $14K |
| 82728 Clinical Chemistry | 377 | 191 | $13.36 | $5,037 |
| 82607 Clinical Chemistry | 264 | 164 | $14.78 | $3,902 |
| 82746 Clinical Chemistry | 210 | 143 | $14.41 | $3,026 |
| 83540 Clinical Chemistry | 175 | 119 | $6.34 | $1,110 |
| 83550 Clinical Chemistry | 174 | 119 | $8.57 | $1,491 |
| 84443 Clinical Chemistry | 167 | 73 | $16.46 | $2,749 |
| 84153 Clinical Chemistry | 145 | 61 | $18.02 | $2,613 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph My prescribed most often to Medicare patients was Prednisone, with 190 prescriptions and refills. In total Joseph My wrote 2,854 Medicare prescriptions that cost $10.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 190 | 222 | 52 | $898 |
| Abiraterone Acetate Generic | 152 | 158 | 27 | $293K |
| Dexamethasone Generic | 127 | 144 | 71 | $2,085 |
| Procrit Epoetin Alfa | 125 | 125 | 23 | $264K |
| Ondansetron Odt Ondansetron | 96 | 98 | 72 | $2,971 |
| Prochlorperazine Maleate Generic | 82 | 83 | 63 | $1,650 |
| Eliquis Apixaban | 82 | 142 | 26 | $81K |
| Orgovyx Relugolix | 70 | 70 | Under 11 | $180K |
| Xarelto Rivaroxaban | 64 | 117 | 14 | $63K |
| Acyclovir Generic | 62 | 127 | 17 | $1,128 |
| Olanzapine Generic | 59 | 118 | 30 | $983 |
| Xtandi Enzalutamide | 58 | 58 | Under 11 | $783K |
| Lenalidomide Generic | 55 | 55 | Under 11 | $696K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 48 | 48 | 15 | $965 |
| Lupron Depot Leuprolide Acetate | 46 | 232 | 32 | $457K |
Brand drugs: 1,040 claims; generic drugs: 1,814 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph My $4,946 ($4,946 in general payments such as food, travel and fees) from 46 companies. The largest payer was Pfizer Inc. with $506.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 29 | $506 |
| Janssen Biotech, Inc. JNJ | 16 | $485 |
| Merck Sharp & Dohme LLC MRK | 17 | $393 |
| Abbvie Inc. ABBV | 16 | $301 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $291 |
| BeOne Medicines USA, Inc. ONC | 7 | $248 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $236 |
| Seagen Inc. PFE | 2 | $200 |
| Celgene Corporation BMY | 9 | $181 |
| Genzyme Corporation SNY | 7 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.